Cocrystal Pharma (8CC.F) Q2 2026 Earnings

May 15Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.45
-0.34
-0.24
-0.13

Details

Expected EPS
-0.1290285
Actual EPS
-0.1462323
Surprise EPS
-0.02
Surprise Percent
-13.33%

Description

⁨Cocrystal Pharma⁩ (⁦8CC.F⁩) has reported earnings of ⁦-0.1462323⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts